Cardiac personalized medicine represents a groundbreaking approach to cardiovascular care, tailoring treatment strategies to an individual's unique genetic makeup, lifestyle factors, and specific cardiac conditions. This emerging field aims to revolutionize how we prevent, diagnose, and treat cardiovascular diseases by recognizing the inherent variability among patients. By leveraging advances in genetics, biomarkers, and diagnostic technologies, cardiac personalized medicine strives to deliver more precise and effective interventions, ultimately improving patient outcomes. This approach holds the promise of ushering in a new era of cardiovascular healthcare that is not only more targeted but also more patient-centric, taking into account the diverse factors that contribute to heart health on an individualized level. As research and technology continue to advance, the prospects for enhancing cardiac care through personalized medicine remain both exciting and full of potential.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain